CANAKINUMAB

UNII:	37CQ2C7X93
Formula:
Preferred Substance Name:	CANAKINUMAB

914613-48-2
ACZ885
ACZ-885
CANAKINUMAB [EMA EPAR]
CANAKINUMAB [INN]
CANAKINUMAB [JAN]
CANAKINUMAB [MART.]
CANAKINUMAB [MI]
CANAKINUMAB [PURPLE BOOK CDER]
CANAKINUMAB [USAN]
CANAKINUMAB [VANDF]
CANAKINUMAB [WHO-DD]
ILARIS
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 1.BETA.) (HUMAN CLONE ACZ885 HEAVY CHAIN V REGION)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 BETA (IL-1.BETA.)) HUMAN MONOCLONAL ACZ885; (1GLU>GLP)-.GAMMA.1 HEAVY CHAIN (221-214')-DISULFIDE WITH KAPPA LIGHT CHAIN, DIMER (227-227'':230-230'')-BISDISULFIDE
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 BETA (IL-1.BETA.)) HUMAN MONOCLONAL ACZ885; (1GLU>GLP)-.GAMMA.1 HEAVY CHAIN (221-214')-DISULPHIDE WITH KAPPA LIGHT CHAIN, DIMER (227-227'':230-230'')-BISDISULPHIDE

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CANAKINUMAB

Synonyms and Mappings

Resources